Cargando…

Targeting cancer cell metabolism in pancreatic adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of cancer death by 2030. Current therapeutic options are limited, warranting an urgent need to explore innovative treatment strategies. Due to specific microenvironment constraints including an extensive desmoplas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Romain, Neuzillet, Cindy, Tijeras-Raballand, Annemilaï, Faivre, Sandrine, de Gramont, Armand, Raymond, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627277/ https://www.ncbi.nlm.nih.gov/pubmed/26164081

Ejemplares similares

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
por: Neuzillet, Cindy, et al.
Publicado: (2013)

Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
por: Serova, Maria, et al.
Publicado: (2015)

Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
por: Boilève, Alice, et al.
Publicado: (2021)

Pancreatic cancer orthotopic graft in a murine model
por: Muzzolini, Milena, et al.
Publicado: (2023)

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
por: Serova, Maria, et al.
Publicado: (2016)

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
por: Neuzillet, Cindy, et al.
Publicado: (2019)

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study
por: Evrard, Diane, et al.
Publicado: (2022)

Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma
por: Neuzillet, Cindy, et al.
Publicado: (2022)

Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma
por: Santos, C D, et al.
Publicado: (2015)

Novel TGF-β inhibitors ready for prime time in onco-immunology
por: de Gramont, Armand, et al.
Publicado: (2016)

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma
por: Tijeras-Raballand, Annemilaï, et al.
Publicado: (2010)

Adjuvant therapies in advanced hepatocellular carcinoma: moving forward from the STORM
por: Bouattour, Mohamed, et al.
Publicado: (2016)

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
por: Hilmi, Marc, et al.
Publicado: (2018)

Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine Compound
por: Serova, Maria, et al.
Publicado: (2013)

Cancer wars: natural products strike back
por: Basmadjian, Christine, et al.
Publicado: (2014)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
por: Turpin, Anthony, et al.
Publicado: (2022)

Identification of a large intra-exonic deletion in BRCA2 exon 18 in a pancreatic ductal adenocarcinoma
por: Debbabi, Inès, et al.
Publicado: (2023)

Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma
por: Neuzillet, Cindy, et al.
Publicado: (2016)

Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trial
por: Neuzillet, Cindy, et al.
Publicado: (2015)

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
por: Rai, Vikrant, et al.
Publicado: (2020)

In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens
por: Lafitte, Marie, et al.
Publicado: (2012)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors
por: Hammel, Pascal, et al.
Publicado: (2020)

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer
por: Raymond, Eric, et al.
Publicado: (2020)

Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective
por: Neuzillet, Cindy, et al.
Publicado: (2023)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
por: Creeden, Justin F., et al.
Publicado: (2020)

Immune Therapy for Liver Cancers
por: Hilmi, Marc, et al.
Publicado: (2019)

Long-Term Survival in Locally Advanced KRAS Wild-Type Pancreatic Adenocarcinoma
por: Alhenc-Gelas, Marion, et al.
Publicado: (2019)

Cholangiocarcinoma: the quest for a second-line systemic treatment
por: Vienot, Angélique, et al.
Publicado: (2019)

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
por: Hilmi, Marc, et al.
Publicado: (2020)

Targeting Redox Metabolism in Pancreatic Cancer
por: Abdel Hadi, Nadine, et al.
Publicado: (2021)

Markers of Bone Metabolism in Patients With Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Pezzilli, Raffaele, et al.
Publicado: (2015)

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
por: Lee, Michael K. C., et al.
Publicado: (2021)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021)

Recent advances in targeted therapy for pancreatic adenocarcinoma
por: Fang, Yu-Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_18m9jfb9kl6i3efsfe280h2p0r